{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T08:46:34Z","timestamp":1791708394849,"version":"4.3.4"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Strongyloidiasis is a neglected tropical disease affecting over 600 million people worldwide. Its severe forms carry a fatality rate exceeding 60%, yet death is rarely attributable to the parasite alone: the terminal event is often bacterial sepsis or meningitis of enteric origin. We review recent evidence on Gram-negative and other bacterial superinfections in severe strongyloidiasis, and their diagnostic and therapeutic implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>\n                      Cohort studies show that bacteraemia is the commonest complication of severe disease, affecting 38.3% of cases against 4.1% of uncomplicated infections, and is predominantly Gram-negative, with\n                      <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                      most often isolated; Gram-positive and polymicrobial infections also occur. Beyond corticosteroids, targeted immunosuppressants and transplantation are increasingly implicated. Recognition is difficult, as eosinophilia is frequently absent and serological tests, including recent rapid assays, perform poorly in immunocompromised patients. Diagnostic delay is associated with higher risk of sepsis and mortality. Emodepside and moxidectin show promise in chronic infection but remain untested in severe disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Enteric Gram-negative bacteraemia or meningitis in an at-risk patient, particularly if recurrent or polymicrobial, should prompt parasitological investigation. As treatment of established disease is unproven, detecting and treating chronic infection before immunosuppression, including transplant donors and recipients, remains the intervention most likely to reduce mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/qco.0000000000001249","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T08:00:07Z","timestamp":1791705607000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Severe strongyloidiasis and Gram-negative bacterial superinfections: epidemiology, clinical implications, and therapeutic strategies"],"prefix":"10.1097","author":[{"given":"Chiara","family":"Sepulcri","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, AOM - IRCCS Ospedale Policlinico San Martino"},{"name":"Department of Health Sciences (DISSAL), University of Genoa, Geneva, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vena","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, AOM - IRCCS Ospedale Policlinico San Martino"},{"name":"Department of Health Sciences (DISSAL), University of Genoa, Geneva, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, AOM - IRCCS Ospedale Policlinico San Martino"},{"name":"Department of Health Sciences (DISSAL), University of Genoa, Geneva, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"R2-20261011","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/pathogens9060468","article-title":"The global prevalence of Strongyloides stercoralis infection","volume":"9","author":"Buonfrate","year":"2020","journal-title":"Pathogens"},{"key":"R3-20261011","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(06)68653-4","article-title":"Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm","volume":"367","author":"Bethony","year":"2006","journal-title":"Lancet"},{"key":"R4-20261011","doi-asserted-by":"crossref","first-page":"e2214","DOI":"10.1371\/journal.pntd.0002214","article-title":"Strongyloides stercoralis: a plea for action","volume":"7","author":"Bisoffi","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"R6-20261011","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2334-13-78","article-title":"Severe strongyloidiasis: a systematic review of case reports","volume":"13","author":"Buonfrate","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R7-20261011","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/CMR.17.1.208-217.2004","article-title":"Strongyloides stercoralis in the immunocompromised population","volume":"17","author":"Keiser","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"R8-20261011","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/trstmh\/trad032","article-title":"Severe strongyloidiasis: a systematic review and meta-analysis of 339 cases","volume":"117","author":"Rojas","year":"2023","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R9-20261011","doi-asserted-by":"crossref","first-page":"e0014252","DOI":"10.1371\/journal.pntd.0014252","article-title":"Predictors of severe strongyloidiasis and mortality in hospitalized patients from Southern Thailand","volume":"20","author":"Chittrakarn","year":"2026","journal-title":"PLoS Negl Trop Dis"},{"key":"R10-20261011","doi-asserted-by":"crossref","first-page":"taab155","DOI":"10.1093\/jtm\/taab155","article-title":"Strongyloidiasis in immunocompromised migrants to nonendemic countries in the era of COVID-19: what is the role for presumptive ivermectin?","volume":"29","author":"Barkati","year":"2022","journal-title":"J Travel Med"},{"key":"R11-20261011","doi-asserted-by":"crossref","first-page":"102952","DOI":"10.1016\/j.tmaid.2026.102952","article-title":"Imported Strongyloides stercoralis infections in Germany: descriptive study of cases over 5\u200ayears in a referral center in Berlin","volume":"70","author":"Seigerschmidt","year":"2026","journal-title":"Travel Med Infect Dis"},{"key":"R12-20261011","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jinf.2006.01.016","article-title":"Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review","volume":"54","author":"Fardet","year":"2006","journal-title":"J Infect"},{"key":"R13-20261011","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3026(23)00031-5","article-title":"Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review","volume":"10","author":"Muhsen","year":"2023","journal-title":"Lancet Haematol"},{"key":"R14-20261011","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/microbiolres16020042","article-title":"Hyperinfection by Strongyloides stercoralis: series of cases in a regional hospital in Southern Spain","volume":"16","author":"Lucas-Dato","year":"2025","journal-title":"Microbiol Res"},{"key":"R15-20261011","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3201\/eid3207.260747","article-title":"Investigation of donor-transmitted strongyloides stercoralis infections in solid organ transplant recipients, United States, 2012\u20132024","volume":"32","author":"Gainor","year":"2026","journal-title":"Emerg Infect Dis"},{"key":"R16-20261011","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jama.2020.13170","article-title":"COVID-19 and dexamethasone: a potential strategy to avoid steroid-related Strongyloides hyperinfection","volume":"324","author":"Stauffer","year":"2020","journal-title":"JAMA"},{"key":"R17-20261011","doi-asserted-by":"crossref","first-page":"taaa113","DOI":"10.1093\/jtm\/taaa113","article-title":"COVID-19: exposing and addressing health disparities among ethnic minorities and migrants","volume":"27","author":"Greenaway","year":"2020","journal-title":"J Travel Med"},{"key":"R18-20261011","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S0031182016000111","article-title":"Strongyloides infection in rodents: immune response and immune regulation","volume":"144","author":"Breloer","year":"2016","journal-title":"Parasitology"},{"key":"R19-20261011","doi-asserted-by":"crossref","first-page":"111511","DOI":"10.1016\/j.molbiopara.2022.111511","article-title":"Is Strongyloides stercoralis hyperinfection induced by glucocorticoids a result of both suppressed host immunity and altered parasite genetics?","volume":"251","author":"Herbert","year":"2022","journal-title":"Mol Biochem Parasitol"},{"key":"R20-20261011","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.0141-9838.2004.00726.x","article-title":"Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis","volume":"26","author":"Carvalho","year":"2004","journal-title":"Parasite Immunol"},{"key":"R21-20261011","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0031182016000834","article-title":"Human infection with Strongyloides stercoralis and other related Strongyloides species","volume":"144","author":"Nutman","year":"2016","journal-title":"Parasitology"},{"key":"R22-20261011","doi-asserted-by":"crossref","first-page":"e0003323","DOI":"10.1128\/cmr.00033-23","article-title":"Human strongyloidiasis: complexities and pathways forward","volume":"36","author":"Buonfrate","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"R23-20261011","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00408-022-00528-z","article-title":"Strongyloides stercoralis","volume":"200","author":"Czeresnia","year":"2022","journal-title":"Lung"},{"key":"R24-20261011","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12879-017-2430-9","article-title":"Pulmonary strongyloidiasis: assessment between manifestation and radiological findings in 16 severe strongyloidiasis cases","volume":"17","author":"Nabeya","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R25-20261011","doi-asserted-by":"crossref","first-page":"e0007998","DOI":"10.1371\/journal.pntd.0007998","article-title":"Severe Strongyloides stercoralis infection in kidney transplant recipients: a multicenter case-control study","volume":"14","author":"Miglioli-Galv\u00e3o","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"R26-20261011","first-page":"e90625","article-title":"Strongyloides stercoralis hyperinfection presenting as ascending cholangitis and Escherichia coli bacteremia in a patient with metastatic pancreatic cancer","volume":"17","author":"Wang","year":"2025","journal-title":"Cureus"},{"key":"R27-20261011","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1186\/s12879-022-07670-2","article-title":"Strongyloides stercoralis hyperinfection syndrome mimicking pseudomembranous enteritis, complicated by Escherichia coli bacteremia and Pneumocystis jirovecii pneumonia in a patient after immunosuppressive therapy: a case report","volume":"22","author":"Cai","year":"2022","journal-title":"BMC Infect Dis"},{"key":"R28-20261011","first-page":"424362","article-title":"E. coli meningitis presenting in a patient with disseminated Strongyloides stercoralis","volume":"2013","author":"Gomez","year":"2013","journal-title":"Case Rep Infect Dis"},{"key":"R29-20261011","first-page":"8634717","article-title":"A case of bacteremia and meningitis associated with piperacillin-tazobactam nonsusceptible, ceftriaxone susceptible Escherichia coli during Strongyloides hyperinfection in an immunocompromised host","volume":"2017","author":"Dahal","year":"2017","journal-title":"Case Rep Infect Dis"},{"key":"R30-20261011","doi-asserted-by":"crossref","first-page":"bcr2013200728","DOI":"10.1136\/bcr-2013-200728","article-title":"Shiga toxin producing E. coli bloodstream infection secondary to Strongyloides penetration through intestinal mucosa","volume":"2013","author":"St Cyr","year":"2013","journal-title":"BMJ Case Rep"},{"key":"R31-20261011","doi-asserted-by":"crossref","first-page":"102378","DOI":"10.1016\/j.jvscit.2026.102378","article-title":"Recurrent mycotic aortic aneurysm with Klebsiella bacteremia and superimposed strongyloidiasis","volume":"12","author":"LaGrone","year":"2026","journal-title":"J Vasc Surg Cases Innov Tech"},{"key":"R32-20261011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2169\/internalmedicine.3403-19","article-title":"Septic meningitis and liver abscess due to hypermucoviscous Klebsiella pneumoniae complicated with chronic strongyloidiasis in a human t-lymphotropic virus 1 carrier","volume":"59","author":"Hosoda","year":"2019","journal-title":"Intern Med"},{"key":"R33-20261011","doi-asserted-by":"crossref","first-page":"e18247","DOI":"10.1097\/MD.0000000000018247","article-title":"Co-infection with Strongyloides stercoralis hyperinfection syndrome and Klebsiella in a nephrotic syndrome patient: a case report","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R34-20261011","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.idcr.2017.09.005","article-title":"Strongyloides hyperinfection syndrome causing fatal meningitis and septicemia by Citrobacter koseri","volume":"10","author":"Reyes","year":"2017","journal-title":"IDCases"},{"key":"R35-20261011","doi-asserted-by":"crossref","first-page":"494755261473036","DOI":"10.1177\/00494755261473036","article-title":"Strongyloides hyperinfection presenting with ulcerative duodenitis and septic shock in a steroid-treated patient","author":"Mohan","year":"2026","journal-title":"Trop Doct"},{"key":"R36-20261011","doi-asserted-by":"crossref","first-page":"e0013380","DOI":"10.1371\/journal.pntd.0013380","article-title":"Factors associated with diagnostic delay and prognosis in hospitalized patients with strongyloidiasis in Okinawa, Japan","volume":"19","author":"Arima","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"key":"R37-20261011","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10096-023-04589-7","article-title":"Streptococcus gallolyticus meningitis and Strongyloides stercoralis hyperinfection in a patient with systemic lupus erythematosus","volume":"42","author":"Hutabarat","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R38-20261011","doi-asserted-by":"crossref","first-page":"e255656","DOI":"10.1136\/bcr-2023-255656","article-title":"Recurrent Klebsiella bacteremia due to chronic strongyloidiasis in the context of cirrhotic hepatopulmonary syndrome","volume":"16","author":"Morris","year":"2023","journal-title":"BMJ Case Rep"},{"key":"R39-20261011","doi-asserted-by":"crossref","DOI":"10.1097\/01.ccm.0001100884.97608.3b","article-title":"555: Recurrent bacterial infections in the setting of strongyloides hyperinfection syndrome","volume":"53","author":"Prado","year":"2025","journal-title":"Crit Care Med"},{"key":"R40-20261011","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4269\/ajtmh.14-0564","article-title":"Five cases of recurrent meningitis associated with chronic strongyloidiasis","volume":"92","author":"Shimasaki","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"R41-20261011","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.22-0109","article-title":"Evaluation of Strongyloides awareness and knowledge among canadian physicians caring for patients at risk for severe strongyloidiasis: a national cross-sectional survey","volume":"107","author":"De l\u2019\u00c9toile-Morel","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"R42-20261011","doi-asserted-by":"crossref","first-page":"e0009076","DOI":"10.1371\/journal.pntd.0009076","article-title":"Performance evaluation of Baermann techniques: the quest for developing a microscopy reference standard for the diagnosis of Strongyloides stercoralis","volume":"15","author":"Gelaye","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"R43-20261011","doi-asserted-by":"crossref","first-page":"101380","DOI":"10.1016\/j.lanmic.2026.101380","article-title":"Accuracy of rapid diagnostic tests for Strongyloides stercoralis detection: a systematic review and meta-analysis","volume":"7","author":"Tamarozzi","year":"2026","journal-title":"Lancet Microbe"},{"key":"R44-20261011","doi-asserted-by":"crossref","first-page":"taaf122","DOI":"10.1093\/jtm\/taaf122","article-title":"Subcutaneous ivermectin treatment in severe strongyloidiasis: is it time to recommend drug concentration measurements and parasitological stool monitoring follow-up?","volume":"33","author":"Allg\u00f6wer","year":"2026","journal-title":"J Travel Med"},{"key":"R45-20261011","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.4269\/ajtmh.18-0387","article-title":"Case report: subcutaneous ivermectin pharmacokinetics in disseminated Strongyloides infection: plasma and postmortem analysis","volume":"99","author":"Konecny","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"R46-20261011","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4269\/ajtmh.2003.68.453","article-title":"Case report: rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome","volume":"68","author":"Tarr","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"R47-20261011","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1473-3099(23)00507-8","article-title":"Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia: a randomised, double-blind, noninferiority, phase 2b\/3 trial","volume":"24","author":"Sprecher","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"R48-20261011","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S1473-3099(25)00255-5","article-title":"Efficacy and safety of ascending doses of emodepside in comparison with ivermectin in adults infected with Strongyloides stercoralis in Laos: a phase 2a, dose-ranging, randomised, parallel-group, placebo-controlled, single-blind clinical trial","volume":"25","author":"Taylor","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"R49-20261011","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4269\/ajtmh.16-0923","article-title":"Evidence-based guidelines for screening and management of strongyloidiasis in non-endemic countries","volume":"97","author":"Requena-M\u00e9ndez","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"R51-20261011","doi-asserted-by":"crossref","first-page":"e13618","DOI":"10.1111\/ctr.13618","article-title":"Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"La Hoz","year":"2019","journal-title":"Clin Transplant"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QCO.0000000000001249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T08:00:14Z","timestamp":1791705614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/QCO.0000000000001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1097\/qco.0000000000001249","relation":{},"ISSN":["0951-7375","1473-6527"],"issn-type":[{"value":"0951-7375","type":"print"},{"value":"1473-6527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]}}}